This study focuses on individuals living with Osteoarthritis, a condition where the protective tissue at the ends of bones wears down over time, causing pain and stiffness, particularly in the knee. The research also involves people who are classified as Overweight or have Obesity, which refers to having an excessive amount of body fat. The purpose of the study is to investigate the efficacy and safety of a medication called Eloralintide, also known by its code LY3841136.
Participants in the study will receive either Eloralintide or a placebo through a subcutaneous injection, which is a method of delivering medication into the fatty tissue just under the skin. The medication is administered once every week using a pre-filled syringe containing a solution for injection. During the course of the study, the changes in body weight and knee pain levels will be monitored over a period of time.



Belgium
Czechia
Denmark
Germany